Century Link Investment Management CO Abb Vie Inc. Transaction History

Century Link Investment Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$73.37 - $98.18 $493,413 - $660,260	-6,725 Closed	0 $0
Q4 2019 Jan 13, 2020	SELL	$72.13 - $90.25 $75,592 - $94,582	-1,048 Reduced 13.48%	6,725 $595,000
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $82,944 - $99,723	-1,317 Reduced 14.49%	7,773 $589,000
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $96,734 - $107,537	-1,088 Reduced 10.69%	9,090 $860,000
Q2 2018 Jul 05, 2018	SELL	$89.78 - $106.23 $92,473 - $109,416	-1,030 Reduced 9.19%	10,178 $943,000
Q4 2017 Jan 08, 2018	BUY	$89.56 - $98.21 $10,836 - $11,883	121 Added 1.09%	11,208 $1.08 Million
Q3 2017 Oct 06, 2017	BUY	$69.85 - $89.22 $774,426 - $989,182	11,087	11,087 $985,000

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Century Link Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Century Link Investment Management CO with notifications on news.